WHAT SCIENTISTS SAY ABOUT DPA OMEGA-3
DPA as a reservoir could be metabolized into DHA, and further retro-conversed back to EPA
The findings showed that DPA as a reservoir could be metabolized into DHA, and further retro-conversed back to EPA. Supplementation with EPA was efficiently incorporated into plasma lipid fractions, whereas incorporation of DHA into plasma lipid fractions was limited within a short period of supplement.
Effect of omega-3 supplementation on neuropathy in type 1 diabetes - A 12-month pilot trial
12 months of seal oil omega-3 polyunsaturated fatty acids (v-3 PUFA) supplementation will stop the known progression of diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes mellitus (T1DM).
Association between Obesity and Omega-3 Status in Healthy Young Women
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are essential for healthy development and protect against metabolic disease. However, individuals with obesity may be pre-disposed to experiencing lower n-3 PUFA status than normal-weight individuals.
Omega-3 Fatty Acid Supplementation Linked to Reduced Inflammation and Flaring in Lupus
Preclinical and clinical studies reveal that consumption of the marine ω-3 highly unsaturated fatty acids (HUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) might be used as a precision nutrition intervention to lessen lupus symptoms.
Higher levels of omega-3s are associated with lower risk of suboptimal sleep
Research: participant ages ranged from 35 to 96 years from 5 countries (Finland, Iceland, Sweden, Singapore, and the United States) with higher circulating omega-3 FAs had a lower risk of suboptimal sleep.